N. O. Bobrova, M. M. Ananieva, E. M. Vazhnichaya, N. O. Vlasenko, N. M. Deviatkina

CLINICAL AND EXPERIMENTAL MEDICINE

Scentific article

COMBINED ACTION OF ANTIMYCOTICS

1. Jabra-Rizk MA, Kong E, Tsui C, Nguyen M, Clancy C, Fidel P, et al. Candida albicans pathogenesis: Fitting within the host-microbe damage response framework. Infect. Immun. 2016;84:2724-2739. DOI: 10.1128/IAI.00469-16.
2. Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L. Clinical practice guideline for the management of candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis. Clin Infect Dis. 2016 Feb 15;62(4):e1-50. DOI: 10.1093/cid/civ933.
3. Wiederhold NP. The antifungal arsenal: alternative drugs and future targets. Int J Antimicrob Agents. 2018 Mar;51(3):333-9. DOI: 10.1016/j. ijantimicag.2017.09. 002.
4. Bona E, Cantamessa S, Pavan M, Novello G, Massa N, Rocchetti A, et al. Sensitivity of Candida albicans to essential oils: are they an alternative to antifungal agents? J Appl Microbiol [Internet]. 2016 Dec [cited 2022 May 10]; 121(6):1530-1545. Available from: https:// sfamjournals.onlinelibrary.wiley.com/ doi/full/10.1111/ jam.13282.
5. Semina SA, Sidorenko SV, Rezvan SP, Grudinina SA, Strachunskiy LS, Stetsyuk OU, el al. Opredelenie chuvstvitelnosti mikroorganizmov k antibakterialnyim preparatam (Metodicheskie ukazaniya MUK 4.2.1890-04). Klin mikrobiol antimikrob himioter. 2004;6(4):306-59. [in Russian].
6. Dikiy IL, Sidorchuk II, Holupyak IYu, Sheveleva NE Mikrobiologiya: Rukovodstvo k laboratornyim zanyatiyam: Uchebnoe posobie dlya studentov farmatsevticheskih VUZov i farmatsevticheskih fakultetov meditsinskih institutov. Kiev: ID «Professional»; 2004. 594 s. [in Russian].

«Bulletin of problems biology and medicine» Issue 2 (164) (addition), 2022 year, 58-59 pages, index UDK 615.281:547.913-08

10.29254/2077-4214-2022-2-164/addition-58-59